Novel and Recurring Disease-Causing NF1 Variants in Two Chinese Families with Neurofibromatosis Type 1
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel and Recurring Disease-Causing NF1 Variants in Two Chinese Families with Neurofibromatosis Type 1
Authors
Keywords
Neurofibromatosis type 1, <em class=EmphasisTypeItalic >NF1</em> gene, Genetic analysis, Genetic counseling, Gene-targeted therapy
Journal
JOURNAL OF MOLECULAR NEUROSCIENCE
Volume 65, Issue 4, Pages 557-563
Publisher
Springer Nature America, Inc
Online
2018-07-25
DOI
10.1007/s12031-018-1128-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The genetics of Parkinson disease
- (2018) Hao Deng et al. AGEING RESEARCH REVIEWS
- Compound heterozygous POMT1 mutations in a Chinese family with autosomal recessive muscular dystrophy-dystroglycanopathy C1
- (2017) Pengzhi Hu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Identification of a missense mutation in the tyrosinase gene in a Chinese family with oculocutaneous albinism type 1
- (2017) Qian Lu et al. Molecular Medicine Reports
- A reference human genome dataset of the BGISEQ-500 sequencer
- (2017) Jie Huang et al. GigaScience
- Mice with missense and nonsenseNF1mutations display divergent phenotypes compared with human neurofibromatosis type I
- (2016) Kairong Li et al. Disease Models & Mechanisms
- NF1germline mutation differentially dictates optic glioma formation and growth in neurofibromatosis-1
- (2016) Joseph A. Toonen et al. HUMAN MOLECULAR GENETICS
- Identification of a Novel Missense FBN2 Mutation in a Chinese Family with Congenital Contractural Arachnodactyly Using Exome Sequencing
- (2016) Hao Deng et al. PLoS One
- Elucidating the impact of neurofibromatosis-1 germline mutations on neurofibromin function and dopamine-based learning
- (2015) C. Anastasaki et al. HUMAN MOLECULAR GENETICS
- High Incidence of Noonan Syndrome Features Including Short Stature and Pulmonic Stenosis in Patients carrying NF1 Missense Mutations Affecting p.Arg1809: Genotype-Phenotype Correlation
- (2015) Kitiwan Rojnueangnit et al. HUMAN MUTATION
- NF1 loss induces senescence during human melanocyte differentiation in an iPSC-based model
- (2015) Lionel Larribere et al. Pigment Cell & Melanoma Research
- Molecular Characterization of NF1 and Neurofibromatosis Type 1 Genotype-Phenotype Correlations in a Chinese Population
- (2015) Jia Zhang et al. Scientific Reports
- Identification of a Novel Mutation in the COL2A1 Gene in a Chinese Family with Spondyloepiphyseal Dysplasia Congenita
- (2015) Xiangjun Huang et al. PLoS One
- p.Arg1809Cys substitution in neurofibromin is associated with a distinctive NF1 phenotype without neurofibromas
- (2014) Valentina Pinna et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Fifty-four novel mutations in the NF1 gene and integrated analyses of the mutations that modulate splicing
- (2014) WEIHONG XU et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Fast and Robust Next-Generation Sequencing Technique Using Ion Torrent Personal Genome Machine for the Screening of Neurofibromatosis Type 1 (NF1) Gene
- (2014) Bernadett Balla et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Neurofibromatosis type 1: a multidisciplinary approach to care
- (2014) Angela C Hirbe et al. LANCET NEUROLOGY
- Identification of a Premature Termination Mutation in the Proline-Rich Transmembrane Protein 2 Gene in a Chinese Family with Febrile Seizures
- (2014) Wen Zheng et al. MOLECULAR NEUROBIOLOGY
- Genetic Modifiers of Neurofibromatosis Type 1-Associated Café-au-Lait Macule Count Identified Using Multi-platform Analysis
- (2014) Alexander Pemov et al. PLoS Genetics
- Mutation Spectrum of NF1 and Clinical Characteristics in 78 Korean Patients With Neurofibromatosis Type 1
- (2013) Jung Min Ko et al. PEDIATRIC NEUROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started